前收市價 | 12.50 |
開市 | 12.50 |
買盤 | 14.70 |
賣出價 | 16.10 |
拍板 | 40.00 |
到期日 | 2025-01-17 |
今日波幅 | 12.50 - 12.50 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 634 |
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.
Biohaven stock tumbled Wednesday after the company's experimental protein-degrading drug lagged investor expectations.